Chikungunya IgM Antibody
Chikungunya is a mosquito-borne viral illness causing fever, severe joint pain, and rash. IgM antibodies appear from day 4–5 of illness, peak at 2–4 weeks, and can persist for several months. In endemic India, chikungunya and dengue often co-circulate — they look clinically similar but chikungunya causes far more severe, prolonged arthralgia. IgM is the most commonly used diagnostic test once the first few days of fever have passed.
Expected Result
Normal
Negative
Best tested from day 5 of fever. Co-testing with dengue IgM is standard in endemic regions.
This is a qualitative test — results are reported as positive or negative rather than as a numeric range. Interpretation may vary by laboratory method; always review with your doctor.
What a Negative Result Means
A negative chikungunya IgM in the first 4 days of fever is expected — antibodies have not yet developed. Repeat from day 5 onwards. Persistently negative IgM after day 7 with severe joint pain makes chikungunya unlikely; consider dengue, arboviral co-infections, and other causes of acute arthritis (septic, reactive, viral).
What a Positive Result Means
A positive chikungunya IgM supports recent chikungunya infection. Management is supportive — paracetamol for fever and pain, adequate hydration, and rest. NSAIDs and aspirin should be avoided until dengue is ruled out because of bleeding risk. Joint pain can persist for weeks to months in a minority of patients — chronic post-chikungunya arthropathy may need rheumatology input.
Frequently Asked Questions
Can chikungunya and dengue be co-infections?
Yes. In India and many tropical regions, both viruses are spread by the same Aedes mosquito and can co-circulate. Co-infection produces more severe illness. Standard febrile panels in these regions test for both simultaneously, sometimes also including Zika, scrub typhus, and malaria depending on the season and location.
How long does post-chikungunya joint pain last?
Most patients recover in 2–4 weeks. However, 20–30% develop chronic post-chikungunya arthralgia lasting 3 months to several years. The pattern is often symmetric and resembles rheumatoid arthritis. Early physical therapy and, in severe cases, short courses of anti-inflammatory or DMARD therapy can help.
Is there a vaccine for chikungunya?
Yes. The first chikungunya vaccine (IXCHIQ) was approved by the US FDA in 2023 and by European authorities in 2024. It is not yet widely available in India as of early 2026. Vaccination is currently recommended only for travelers to high-risk outbreak areas. Population-level vaccination decisions are being assessed by Indian health authorities.
Related Infectious tests
See all →ASO Titre (Anti-Streptolysin O)
Antibody against streptococcal toxin — evidence of recent strep infection.
IU/mLInfectiousWidal Test
Antibody test for typhoid fever — used cautiously due to specificity issues.
InfectiousDengue NS1 Antigen
Early dengue virus antigen — detectable in the first week of fever.
InfectiousDengue IgM Antibody
Antibody that rises in the second week of dengue infection.
This information is for educational purposes only and should not replace professional medical advice. Always consult your doctor for interpretation of your test results.
Read Full Medical Disclaimer →